GENE ONLINE|News &
Opinion
Blog

2025-10-15|

New Benzoyl Sesquiterpenoid Compound Identified in Mutant Talaromyces Strain KTF-0021

by Mark Chiang
Share To

Researchers have identified a new benzoyl sesquiterpenoid compound in the mutant fungal strain *Talaromyces* sp. KTF-0021, derived from the FKI-5759 strain. This discovery emerged from efforts to activate silent biosynthetic gene clusters (BGCs) within fungi, which are known to produce a wide range of bioactive natural products. The findings highlight the potential of fungal strains as sources for novel chemical compounds.

The study focused on exploring previously unexpressed BGCs in *Talaromyces* sp., aiming to uncover unique metabolites with potential applications. By inducing mutations in the original FKI-5759 strain, researchers successfully activated dormant genetic pathways, leading to the production of this newly identified benzoyl sesquiterpenoid. The work underscores the importance of investigating fungal biosynthesis and its role in generating diverse and unexplored natural compounds.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: October 15, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
LATEST
Contagious Yawning May Start in the Womb, Study in *Current Biology* Reveals
2026-05-10
New Medication Combinations Show Promise for Treatment-Resistant Depression in *JAMA Psychiatry* Study
2026-05-10
Ellomay Capital Completes Sale of Dorad Energy Holdings on May 10, 2026
2026-05-10
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
India’s Pharmaceutical Growth Slows: Industry Needs New Strategies
2026-05-10
Scroll to Top